Top Markets
#1 Official Trump Official Trump +34.04%
#2 Tutorial Tutorial +32.78%
#3 Siacoin Siacoin +22.29%
#4 EXOD EXOD +22.08%
#5 Mubarak Mubarak +21.21%
#6 Melania Meme Melania Meme +20.62%
#7 MowCat MowCat +19.08%
#8 Unit Pump Unit Pump +18.96%
#9 Pump.fun Pump.fun +18.96%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +17.98%
Coin of the day
Official Trump Official Trump
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc.

OPNT
Rang in aandelen #22841
Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical... Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical enterprise, primarily focused on inventing remedies for both various addictions and drug overdoses. A key product in their current portfolio is NARCAN nasal spray, which provides a critical solution for counteracting opioid overdoses. Their development pipeline is robust, featuring several promising drug candidates designed to address further opioid overdose reversal needs, alcohol use disorders, acute cannabinoid overdose, and opioid use disorders. The company, which established itself in 2005, was initially named Lightlake Therapeutics Inc. before rebranding as Opiant Pharmaceuticals, Inc. in January 2016. Its corporate headquarters are located in Santa Monica, California.
Aandeelprijs
$20.65
Laatst gesynchroniseerd: 2023-03-01
Marktkapitalisatie
$82.52M
Verandering (1 dag)
-0.58%
Verandering (1 jaar)
0.00%
Land
US
Handel Opiant Pharmaceuticals, Inc. (OPNT)

Categorie

Healthcare
Winst voor Opiant Pharmaceuticals, Inc. (OPNT)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van Opiant Pharmaceuticals, Inc. bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Opiant Pharmaceuticals, Inc. van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH